Q
Quentin A. Hill
Researcher at Leeds Teaching Hospitals NHS Trust
Publications - 71
Citations - 1914
Quentin A. Hill is an academic researcher from Leeds Teaching Hospitals NHS Trust. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 19, co-authored 60 publications receiving 1159 citations. Previous affiliations of Quentin A. Hill include Leeds General Infirmary & National Health Service.
Papers
More filters
Journal ArticleDOI
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jäger,Wilma Barcellini,Catherine Broome,Morie A. Gertz,Anita Hill,Quentin A. Hill,Bernd Jilma,David J. Kuter,Marc Michel,Marco Montillo,Alexander Röth,Sacha Zeerleder,Sigbjørn Berentsen +12 more
TL;DR: The First International Consensus Group recommended that Corticosteroids remain first-line therapy for warm-AIHA, while the addition of rituximab should be considered early in severe cases and if no prompt response to steroids is achieved.
Journal ArticleDOI
The diagnosis and management of primary autoimmune haemolytic anaemia.
TL;DR: In this article, the authors provide healthcare professionals with guidance on the management of patients with primary autoimmune haemolytic anaemia (AIHA) by investigating and diagnosis of adult and paediatric AIHA.
Journal ArticleDOI
CNS prophylaxis in lymphoma: Who to target and what therapy to use
Quentin A. Hill,Roger G. Owen +1 more
TL;DR: CNS prophylaxis for selected patients with DLBCL may be justified by risk but its benefit is not yet proven and in combination with intrathecal methotrexate would be a reasonable option for proPHylaxis.
Journal ArticleDOI
Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic.
Sue Pavord,Jecko Thachil,Beverley J. Hunt,Michael F. Murphy,Gillian C. Lowe,Michael Laffan,Michael Makris,Adrian C. Newland,Drew Provan,John D. Grainger,Quentin A. Hill +10 more
TL;DR: This document aims to provide practical guidance for the assessment and management of patients with thrombocytopenia during the COVID‐19 pandemic, with a particular focus on immune throm bocy topenia (ITP), during the coagulation disorders pandemic.
Journal ArticleDOI
Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia
TL;DR: Although recommendations are unchanged, an expanded version of this guideline is available as Appendix S2, and the Grading of Recommendations Assessment, Development and Evaluation nomenclature was used to evaluate levels of evidence and to assess the strength of recommendations.